Logo
x

Search category

Subscribe Now

Duchenne Muscular Dystrophy DMD

Sarepta's Amondys 45 (casimersen) Receives the US FDA's Approval for DMD in Patients Amenable to Skipping Exon 4

Sarepta's Amondys 45 (casimersen) Receives the US FDA's Approval for DMD in Patients Amenable to Skipping Exon 4

  • February 25, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.